Patents Assigned to Otologic Pharmaceutics, Inc.
  • Publication number: 20180200192
    Abstract: Disclosed herein are compositions comprising a first compound that is N-acetylcysteine or a salt thereof, optionally a second compound that is a pharmaceutically acceptable compound capable of forming a radical adduct; and a coating layer encapsulating at least the first compound. Also disclosed are methods of use and manufacture.
    Type: Application
    Filed: January 18, 2018
    Publication date: July 19, 2018
    Applicant: Otologic Pharmaceutics, Inc.
    Inventor: Richard E. Gammans